<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0121-5256</journal-id>
<journal-title><![CDATA[Revista Med]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. Med]]></abbrev-journal-title>
<issn>0121-5256</issn>
<publisher>
<publisher-name><![CDATA[Universidad Militar Nueva Granada. Facultad de Medicina]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0121-52562024000200107</article-id>
<article-id pub-id-type="doi">10.18359/rmed.7193</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Síndrome de lisis tumoral espontáneo en paciente con diagnóstico de cáncer de colon metastásico]]></article-title>
<article-title xml:lang="en"><![CDATA[Spontaneous Tumor Lysis Syndrome in a Patient with Metastatic Colon Cancer]]></article-title>
<article-title xml:lang="pt"><![CDATA[Síndrome de Use tumoral espontânea em paciente com diagnóstico de câncer de cólon metastático]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Russi Noguera]]></surname>
<given-names><![CDATA[July Andrea]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Trujillo Rincón]]></surname>
<given-names><![CDATA[John Fernando]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Hospital Universitario San Ignacio Centro javeriano de Oncología ]]></institution>
<addr-line><![CDATA[Bogotá ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Pontificia Universidad Javeriana Hospital Universitario San Ignacio ]]></institution>
<addr-line><![CDATA[Bogotá ]]></addr-line>
<country>Colombia</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2024</year>
</pub-date>
<volume>32</volume>
<numero>2</numero>
<fpage>107</fpage>
<lpage>113</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_arttext&amp;pid=S0121-52562024000200107&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_abstract&amp;pid=S0121-52562024000200107&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_pdf&amp;pid=S0121-52562024000200107&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen:  Introducción: el síndrome de lisis tumoral (SLT) es una urgencia oncológica metabólica que conlleva mayor riesgo de morbimortalidad; está asociado al tratamiento con quimioterapia de enfermedades neoplásicas, es frecuente en pacientes con neoplasias hematológicas malignas tras el inicio del manejo sistémico; sin embargo, también puede presentarse de forma espontánea o en tumores sólidos.  Presentación del caso:  presentamos el caso de un paciente con diagnóstico de adenocarcinoma de colon metastásico, que presentó un síndrome de lisis tumoral espontáneo, de interés particular por su presentación clínica de forma &#8220;espontánea" en ausencia de tratamiento citotóxico, en un tumor no hematológico y además de manera oligosintomática.  Conclusiones:  el síndrome de lisis tumoral espontáneo asociado a neoplasia sólida constituye una urgencia oncológica de presentación poco frecuente, sin embargo, es necesario conocerlo, pues desarrolla alteraciones metabólicas como: hiperuricemia, hiperfosfatemia, hipocalcemia, hiperkalemia y lesión renal, que requieren manejo agresivo con el fin de evitar morbimortalidad.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract:  Introduction:  Tumor lysis syndrome (TLS) is a metabolic oncological emergency that poses a higher risk of morbidity and mortality. It is associated with chemotherapy treatment for neoplastic diseases and is common in patients with malignant hematological neoplasms after the initiation of systemic management; however, it can also occur spontaneously or in solid tumors.  Case Presentation:  We present the case of a patient diagnosed with metastatic colon adenocarcinoma who developed spontaneous tumor lysis syndrome. This case is of particular interest due to its "spontaneous" clinical presentation in the absence of cytotoxic treatment, in a non-hematological tumor, and in an oligosymptomatic manner.  Conclusions:  Spontaneous tumor lysis syndrome associated with solid neoplasms is an uncommon oncological emergency. However, it is essential to recognize it, as it leads to metabolic disturbances such as hyperuricemia, hyperphosphatemia, hypocalcemia, hyperkalemia, and renal injury, which require aggressive management to prevent morbidity and mortality.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo:  Introdução:  a síndrome de lise tumoral (SLT) é uma emergência oncológica metabólica que acarreta maior risco de morbimortalidade. Está associado ao tratamento quimioterápico de doenças neoplásicas, sendo comum em pacientes com neoplasias hematológicas malignas após o início do manejo sistêmico. No entanto, também pode ocorrer de forma espontânea ou em tumores sólidos.  Apresentação do caso:  apresentamos o caso de um paciente com adenocarcinoma de cólon metastático que apresentou uma síndrome de lise tumoral espontânea, relevante pela manifestação &#8220;espontânea&#8221;, sem tratamento citotóxico, em um tumor não hematológico e de forma oligossintomática.  Conclusões:  a síndrome de lise tumoral espontânea associada a neoplasia sólida é uma emergência oncológica rara, mas é essencial reconhecê-la, pois gera alterações metabólicas, como: hiperuricemia, hiperfosfatemia, hipocalcemia, hipercalemia e lesão renal, o que requere manejo agressivo para evitar morbimortalidade.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[cáncer de colon]]></kwd>
<kwd lng="es"><![CDATA[síndrome de lisis tumoral]]></kwd>
<kwd lng="es"><![CDATA[síndrome de lisis tumoral espontáneo]]></kwd>
<kwd lng="es"><![CDATA[emergencia oncológica]]></kwd>
<kwd lng="es"><![CDATA[reporte de caso]]></kwd>
<kwd lng="en"><![CDATA[Colon Cancer]]></kwd>
<kwd lng="en"><![CDATA[Tumor Lysis Syndrome]]></kwd>
<kwd lng="en"><![CDATA[Spontaneous Tumor Lysis Syndrome]]></kwd>
<kwd lng="en"><![CDATA[Oncological Emergency]]></kwd>
<kwd lng="en"><![CDATA[Case Report]]></kwd>
<kwd lng="pt"><![CDATA[câncer de cólon]]></kwd>
<kwd lng="pt"><![CDATA[síndrome de lise tumoral]]></kwd>
<kwd lng="pt"><![CDATA[síndrome de lise tumoral espontâneo]]></kwd>
<kwd lng="pt"><![CDATA[emergência oncológica]]></kwd>
<kwd lng="pt"><![CDATA[relato de caso]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Puri]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Sharma]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Gunturu]]></surname>
<given-names><![CDATA[KS]]></given-names>
</name>
<name>
<surname><![CDATA[Ahmed]]></surname>
<given-names><![CDATA[AA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Diagnosis and management of tumor lysis syndrome]]></article-title>
<source><![CDATA[J Community Hosp Intern Med Perspect]]></source>
<year>2020</year>
<volume>10</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>269-72</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Howard]]></surname>
<given-names><![CDATA[SC]]></given-names>
</name>
<name>
<surname><![CDATA[Jones]]></surname>
<given-names><![CDATA[DP]]></given-names>
</name>
<name>
<surname><![CDATA[Pui]]></surname>
<given-names><![CDATA[CH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The tumor lysis syndrome]]></article-title>
<source><![CDATA[New England Journal of Medicine]]></source>
<year>2011</year>
<volume>364</volume>
<numero>19</numero>
<issue>19</issue>
<page-range>1844-54</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rahmani]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Patel]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Seyam]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Gandhi]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Reid]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Smith]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Current understanding of tumor lysis syndrome]]></article-title>
<source><![CDATA[Hematological Oncology]]></source>
<year>2019</year>
<volume>37</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>537-47</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shaforostova]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Fiedler]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Zander]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Pflumm]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Márz]]></surname>
<given-names><![CDATA[WJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Fatal spontaneous tumor lysis syndrome in a patient with metastatic colon cancer: a clinical case of rare oncological emergency]]></article-title>
<source><![CDATA[Case Reports in Gastroenterology]]></source>
<year>2020</year>
<volume>14</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>255-60</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Criscuolo]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Fianchi]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Dragonetti]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Pagano]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Tumor lysis syndrome: review of pathogenesis, risk factors and management of a medical emergency]]></article-title>
<source><![CDATA[Expert Review of Hematology]]></source>
<year>2016</year>
<volume>9</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>197-208</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Coiffier]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Riouffol]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Management of tumor lysis syndrome in adults]]></article-title>
<source><![CDATA[Expert Review of Anticancer Therapy]]></source>
<year>2007</year>
<volume>7</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>233-9</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mott]]></surname>
<given-names><![CDATA[FE]]></given-names>
</name>
<name>
<surname><![CDATA[Esana]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Chakmakjian]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Herrington]]></surname>
<given-names><![CDATA[JD]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Tumor lysis syndrome in solid tumors]]></article-title>
<source><![CDATA[Supportive Cancer Therapy]]></source>
<year>2005</year>
<volume>2</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>188-91</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gokmen-Akoz]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Yildirim]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Engin]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Dagdas]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Ozet]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Ozel Tekin]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[An unusual case of spontaneous acute tumor lysis syndrome associated with acute lymphoblastic leukemia: A case report and review of the literature]]></article-title>
<source><![CDATA[Acta Oncológica]]></source>
<year>2007</year>
<volume>46</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>1190-2</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gemici]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Tumour lysis syndrome in solid tumours]]></article-title>
<source><![CDATA[Clinical Oncology]]></source>
<year>2006</year>
<volume>18</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>773-80</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Montesinos]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Lorenzo]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Martín]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Sanz]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez-Sirvent]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
<name>
<surname><![CDATA[Martínez]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Tumor lysis syndrome in patients with acute myeloid leukemia: identification of risk factors and development of a predictive model]]></article-title>
<source><![CDATA[Haematologica]]></source>
<year>2008</year>
<volume>93</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>67-74</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Coiffier]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Acute tumor lysis syndrome - a rare complication in the treatment of solid tumors]]></article-title>
<source><![CDATA[Oncology Research and Treatment]]></source>
<year>2010</year>
<volume>33</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>498-9</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yarpuzlu]]></surname>
<given-names><![CDATA[AA.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A review of clinical and laboratory findings and treatment of tumor lysis syndrome]]></article-title>
<source><![CDATA[Clinica Chimica Acta]]></source>
<year>2003</year>
<volume>333</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>13-8</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cairo]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
<name>
<surname><![CDATA[Bishop]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Tumour lysis syndrome: new therapeutic strategies and classification]]></article-title>
<source><![CDATA[Br J Haematol]]></source>
<year>2004</year>
<volume>127</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>3-11</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Matuszkiewicz-Rowinska]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Malyszko]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevention and treatment of tumor lysis syndrome in the era of onco-nephrology progress]]></article-title>
<source><![CDATA[Kidney and Blood Pressure Research]]></source>
<year>2020</year>
<volume>45</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>645-60</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kearney]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[EY]]></given-names>
</name>
<name>
<surname><![CDATA[Stenzel]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Corless]]></surname>
<given-names><![CDATA[CL]]></given-names>
</name>
<name>
<surname><![CDATA[Deloughery]]></surname>
<given-names><![CDATA[TG]]></given-names>
</name>
<name>
<surname><![CDATA[Zivney]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Colorectal cancer-associated spontaneous tumor lysis syndrome: A case report and review of the current literature]]></article-title>
<source><![CDATA[Journal of Gastrointestinal Cancer]]></source>
<year>2019</year>
<volume>50</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>668-73</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sommerhalder]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Takalkar]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Shackelford]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Peddi]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Spontaneous tumor lysis syndrome in colon cancer: a case report and literature review]]></article-title>
<source><![CDATA[Clinical Case Reports]]></source>
<year>2017</year>
<volume>5</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>2121-6</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
